Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.955
-0.015 (-0.51%)
At close: Aug 1, 2025, 4:00 PM
2.950
-0.005 (-0.17%)
After-hours: Aug 1, 2025, 7:22 PM EDT

Compass Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2020
408200199633309-
Upgrade
Market Cap Growth
-3.56%0.34%-68.61%105.02%--
Upgrade
Enterprise Value
3027137516292-
Upgrade
Last Close Price
2.951.451.565.033.17-
Upgrade
PS Ratio
479.92234.71----
Upgrade
PB Ratio
3.701.591.343.492.21-
Upgrade
P/TBV Ratio
3.701.591.343.492.21-
Upgrade
EV/Sales Ratio
354.9283.51----
Upgrade
Debt / Equity Ratio
0.060.050.010.020.030.23
Upgrade
Asset Turnover
0.010.01----
Upgrade
Quick Ratio
7.5614.2819.5411.5413.594.66
Upgrade
Current Ratio
8.3314.9619.7312.0513.844.97
Upgrade
Return on Equity (ROE)
-41.31%-36.07%-25.74%-24.39%-91.30%-115.21%
Upgrade
Return on Assets (ROA)
-26.41%-23.81%-17.66%-14.73%-19.00%-42.25%
Upgrade
Return on Capital (ROIC)
-28.09%-25.09%-18.80%-15.84%-20.21%-45.80%
Upgrade
Earnings Yield
-13.54%-24.75%-21.37%-6.19%-26.60%-
Upgrade
FCF Yield
-10.84%-22.50%-20.44%-5.42%-6.98%-
Upgrade
Buyback Yield / Dilution
-6.33%-8.15%-20.76%-67.31%-104.28%-359.96%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q